These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 39088033

  • 21. Randomized, crossover, open-label study of the relative bioavailability and safety of FT218, a once-nightly sodium oxybate formulation: Phase 1 study in healthy volunteers.
    Bogan R, Thorpy MJ, Winkelman JW, Dubow J, Gudeman J, Seiden D.
    Sleep Med; 2022 Dec; 100():442-447. PubMed ID: 36252412
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Effect of sodium oxybate, modafinil, and their combination on disrupted nighttime sleep in narcolepsy.
    Dauvilliers Y, Roth T, Guinta D, Alvarez-Horine S, Dynin E, Black J.
    Sleep Med; 2017 Dec; 40():53-57. PubMed ID: 29221779
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Effect of sodium oxybate on body mass index in pediatric patients with narcolepsy.
    Dauvilliers Y, Lammers GJ, Lecendreux M, Maski K, Kansagra S, Black J, Parvataneni R, Chen A, Wang YG, Plazzi G.
    J Clin Sleep Med; 2024 Mar 01; 20(3):445-454. PubMed ID: 37942930
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Sodium oxybate: new drug. Fewer attacks of cataplexy in some patients.
    Prescrire Int; 2007 Jun 01; 16(89):98-101. PubMed ID: 17582923
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Management of Narcolepsy.
    Barateau L, Lopez R, Dauvilliers Y.
    Curr Treat Options Neurol; 2016 Oct 01; 18(10):43. PubMed ID: 27549768
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. EFNS guidelines on management of narcolepsy.
    Billiard M, Bassetti C, Dauvilliers Y, Dolenc-Groselj L, Lammers GJ, Mayer G, Pollmächer T, Reading P, Sonka K, EFNS Task Force.
    Eur J Neurol; 2006 Oct 01; 13(10):1035-48. PubMed ID: 16987156
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Preferences for Attributes of Sodium Oxybate Treatment: A Discrete Choice Experiment in Patients with Narcolepsy.
    Dubow J, Avidan AY, Corser B, Athavale A, Seiden D, Kushida C.
    Patient Prefer Adherence; 2022 Oct 01; 16():937-947. PubMed ID: 35422617
    [Abstract] [Full Text] [Related]

  • 37. Sodium oxybate: a review of its use in the management of narcolepsy.
    Robinson DM, Keating GM.
    CNS Drugs; 2007 Oct 01; 21(4):337-54. PubMed ID: 17381187
    [Abstract] [Full Text] [Related]

  • 38. RESTORE: Once-nightly oxybate dosing preference and nocturnal experience with twice-nightly oxybates.
    Roy A, Stern T, Harsh J, Hudson JD, Ajayi AO, Corser BC, Mignot E, Santamaria A, Morse AM, Abaluck B, Ibrahim S, Schweitzer PK, Lancaster K, Dubow J, Gudeman J.
    Sleep Med X; 2024 Dec 15; 8():100122. PubMed ID: 39263597
    [Abstract] [Full Text] [Related]

  • 39. A 12-month, open-label, multicenter extension trial of orally administered sodium oxybate for the treatment of narcolepsy.
    Sleep; 2003 Feb 01; 26(1):31-5. PubMed ID: 12627729
    [Abstract] [Full Text] [Related]

  • 40. Effect of sodium oxybate on disrupted nighttime sleep in patients with narcolepsy.
    Roth T, Dauvilliers Y, Guinta D, Alvarez-Horine S, Dynin E, Black J.
    J Sleep Res; 2017 Aug 01; 26(4):407-414. PubMed ID: 27807903
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.